Culture

At the core of the Integrator complex

Gene expression is a highly regulated process, which involves several steps. These include transcription of DNA instructions into RNA, removal of non-coding segments from the RNA message, and its subsequent translation into proteins. All these steps involve specific molecular machineries responsible for conducting each process with high accuracy. The Galej group, based at EMBL Grenoble, studies the structure and function of the RNA-protein complexes that are involved in the regulation of gene expression.

During transcription, genetic information contained in the DNA is used to create a precursor messenger RNA (pre-mRNA) thanks to the action of an enzyme, RNA Polymerase II. To maintain only the necessary coding segments required to produce a protein, short fragments of the pre-mRNA are kept and others are removed . This process is known as pre-mRNA splicing and is catalysed by a large and dynamic RNA-protein complex, the spliceosome. This is a key focus of study for the Galej group, for which they have recently received an ERC grant.

More than 100 proteins and five small nuclear RNAs (snRNAs) are involved in building the spliceosome complex and orchestrating pre-mRNA splicing. Before the snRNAs can be incorporated into the spliceosome, they need to undergo an endonucleolytic processing step (in other words, a process where an enzyme has to cut the RNA, also called 3'-end processing), which is catalysed by the Integrator complex. Discovered fifteen years ago, Integrator remained largely uncharacterised structurally, which triggered the Galej group's interest.

Unveiling the structure of key components and their interaction network

Until recently, the Integrator complex was thought to be involved mainly in the 3'-end processing of snRNAs, but studies in the past four years have begun to suggest that this might not be its major function. "We - and the scientific community - originally thought that the Integrator complex was specialised in cutting only one specific type of RNA, snRNA, but recently researchers started to realise that it is actually doing a lot more and influences thousands of RNAs from different classes. More and more evidence suggests that Integrator is one of the key players in global transcription regulation in higher eukaryotes," explains group leader Wojtek Galej.

Recent investigation has revealed that the Integrator complex is broadly involved in the transcription attenuation process, meaning that it can make sure some genes are not expressed. Playing such an essential role in the regulation of gene expression gives even more reason to have a closer look at its molecular structure.

To study the large and dynamic 14-subunit Integrator complex, the Galej group had to combine biochemistry, cell biology, and cryo-electron microscopy (cryo-EM) imaging to determine its architecture. "A very talented PhD student in the group, Moritz Pfleiderer, used cell biology and mass spectrometry methods to first dissect this big complex into smaller modules, which are easier to handle. It was a classic divide and conquer approach," says Galej. "Then Moritz obtained the structure of Integrator's catalytic core using single-particle cryo-EM". For data collection and structure determination of these subcomplexes, the group had access to cryo-EM platforms at EMBL Heidelberg and the local CM01 beamline at the ESRF, which is run with the involvement of EMBL scientists.

Cryo-EM data allowed the scientists to establish the structure and the specific arrangement of the proteins comprising Integrator's catalytic core - the part of the complex responsible for cutting the RNA during the primary transcription process. This discovery provides insights into the interfaces between these proteins, the mechanisms involved, and how they come together inside the cell.

The results, recently published in Molecular Cell alongside the structural analysis, highlight that this complex is composed of a network of multiple subunits interacting with one another. However, several subunits have been identified as stable modules, most tightly associated with each other. "If you try to break down this complex, it will be divided into three or four different pieces, which quite likely constitute its building blocks inside the cell," says Galej.

Leads for future investigation

With this new structure, the Galej group has come up with some new ideas about how RNA could be recognised by the Integrator complex. These are important insights, as they suggest how the substrate might be delivered to the enzyme's active site, where the reaction happens. Interestingly, Integrator has some similarities with other cellular machineries involved in the 3'-end processing of the messenger RNAs that encode proteins. However, the inner arrangement of the Integrator proteins is quite unique compared with the other 3'-end processing complexes, and some proteins are twisted in their positions. This peculiar architecture could have played an important role in the specialisation of this complex, which evolved to fulfil different functions.

Although the study provides the first insights into the architecture of Integrator's catalytic core, more investigations are needed to characterise additional parts of the complex and their involvement in gene expression. Ongoing studies in the Galej group should provide such insights, as well as unravelling the molecular basis of some of the genetic disorders associated with mutations in the components of the Integrator complex, which can result in neurodevelopmental disorders. These studies could facilitate drug design to target these mutations in the future.

Credit: 
European Molecular Biology Laboratory

Research establishes a new method to predict individual risk of cognitive decline

The early prognosis of high-risk older adults for amnestic mild cognitive impairment (aMCI), using noninvasive and sensitive neuromarkers, is key for early prevention of Alzheimer's disease. A recent study, published in the Journal of Alzheimer's Disease, by researchers at the University of Kentucky establishes what they believe is a new way to predict the risk years before a clinical diagnosis. Their work shows that direct measures of brain signatures during mental activity are more sensitive and accurate predictors of memory decline than current standard behavioral testing.

"Many studies have measured electrophysiological rhythms during resting and sleep to predict Alzheimer's risk. This study demonstrates that better predictions of a person's cognitive risk can be made when the brain is challenged with a task. Additionally, we learned that out of thousands of possible brain oscillation measures, left-frontal brainwaves during so-called working memory tasks are good predictors for dementia risk," explained lead investigator Yang Jiang, associate professor of behavioral sciences and an affiliated faculty member at the Sanders-Brown Center on Aging.

When looking for a specific car in a large parking lot, older persons increasingly make more mistakes and take more time than young people due to brain and cognitive aging. Jiang says it has already been reported that brain waves associated with that type of daily memory task differ in cognitively normal older people and those of patients with memory loss and dementia. For this new study, researchers followed healthy older adults for 10 years. They reported that a specific pattern of frontal brainwaves during an everyday memory task predicts a person's risk of cognitive impairment roughly five years before clinical diagnosis. This pattern was not observed in older people who remained cognitively normal over the next 10 years.

Jiang says predicting and preventing cognitive decline is very important to allow preventive measures, such as life-style changes, and for researchers to help achieve a greater quality of life for the rapidly growing aging population. "Compared to current methods using neuroimaging as biomarkers, this method of measuring can be easily set up in clinics, is non-invasive, fast and affordable. Also, reliably predicting the risk of cognitive decline in an individual is new. Our older participants will soon be able to have better version of brainwave tests here at UK."

The clinical and translation work of this study was a team science effort with multiple investigators from UK's Sanders-Brown Center on Aging serving as coauthors including Erin Abner, Richard Kryscio, Greg Jicha, Fred Schmitt, Charles Smith, and collaborators from the Oak Ridge National Laboratory, University of Tennessee, and the Institute of Psychology, Beijing China.

This project was brought to SBCoA by scientists at the Oak Ridge National Laboratory co-author Nancy Munro to David Wekstein and Drs. William Markesbery and Charles Smith nearly 15 years ago with funding from the Department of Energy. The research team received funding from NIH in recent years to expand this work in large-scale and diverse populations. Jiang says their longitudinal study underscores the importance of having a successful Alzheimer's research center at UK.

Linda Van Eldik, director of the Sanders-Brown Center on Aging, said, "This further emphasizes the long-standing national and international reputation of UK's Sanders-Brown Center on Aging and the high quality of our investigators and the research they do."

Credit: 
University of Kentucky

New AI tool can thwart coronavirus mutations

USC researchers have developed a new method to counter emergent mutations of the coronavirus and hasten vaccine development to stop the pathogen responsible for killing thousands of people and ruining the economy.

Using artificial intelligence (AI), the research team at the USC Viterbi School of Engineering developed a method to speed the analysis of vaccines and zero in on the best potential preventive medical therapy.

The method is easily adaptable to analyze potential mutations of the virus, ensuring the best possible vaccines are quickly identified -- solutions that give humans a big advantage over the evolving contagion. Their machine-learning model can accomplish vaccine design cycles that once took months or years in a matter of seconds and minutes, the study says.

"This AI framework, applied to the specifics of this virus, can provide vaccine candidates within seconds and move them to clinical trials quickly to achieve preventive medical therapies without compromising safety," said Paul Bogdan, associate professor of electrical and computer engineering at USC Viterbi and corresponding author of the study. "Moreover, this can be adapted to help us stay ahead of the coronavirus as it mutates around the world."

The findings appear today in Nature Research's Scientific Reports

When applied to SARS-CoV-2 -- the virus that causes COVID-19 -- the computer model quickly eliminated 95% of the compounds that could've possibly treated the pathogen and pinpointed the best options, the study says.

The AI-assisted method predicted 26 potential vaccines that would work against the coronavirus. From those, the scientists identified the best 11 from which to construct a multi-epitope vaccine, which can attack the spike proteins that the coronavirus uses to bind and penetrate a host cell. Vaccines target the region -- or epitope -- of the contagion to disrupt the spike protein, neutralizing the ability of the virus to replicate.

Moreover, the engineers can construct a new multi-epitope vaccine for a new virus in less than a minute and validate its quality within an hour. By contrast, current processes to control the virus require growing the pathogen in the lab, deactivating it and injecting the virus that caused a disease. The process is time-consuming and takes more than one year; meanwhile, the disease spreads.

USC method could help counter COVID-19 mutations

The method is especially useful during this stage of the pandemic as the coronavirus begins to mutate in populations around the world. Some scientists are concerned that the mutations may minimize the effectiveness of vaccines by Pfizer and Moderna, which are now being distributed. Recent variants of the virus that have emerged in the United Kingdom, South Africa and Brazil seem to spread more easily, which scientists say will rapidly lead to many more cases, deaths and hospitalizations.

But Bogdan said that if SARS-CoV-2 becomes uncontrollable by current vaccines, or if new vaccines are needed to deal with other emerging viruses, then USC's AI-assisted method can be used to design other preventive mechanisms quickly.

For example, the study explains that the USC scientists used only one B-cell epitope and one T-cell epitope, whereas applying a bigger dataset and more possible combinations can develop a more comprehensive and quicker vaccine design tool. The study estimates the method can perform accurate predictions with over 700,000 different proteins in the dataset.

"The proposed vaccine design framework can tackle the three most frequently observed mutations and be extended to deal with other potentially unknown mutations," Bogdan said.

The raw data for the research comes from a giant bioinformatics database called the Immune Epitope Database (IEDB) in which scientists around the world have been compiling data about the coronavirus, among other diseases. IEDB contains over 600,000 known epitopes from some 3,600 different species, along with the Virus Pathogen Resource, a complementary repository of information about pathogenic viruses. The genome and spike protein sequence of SARS-CoV-2 comes from the National Center for Biotechnical Information.

COVID-19 has led to 87 million cases and more than 1.88 million deaths worldwide, including more than 400,000 fatalities in the United States. It has devastated the social, financial and political fabric of many countries.

The study authors are Bogdan, Zikun Yang and Shahin Nazarian of the Ming Hsieh Department of Electrical and Computer Engineering at USC Viterbi.

Support for the study comes from the National Science Foundation (NSF) under the Career Award (CPS/CNS-1453860) and NSF grants (CCF-1837131, MCB-1936775 and CNS-1932620); a U.S. Army Research Office grant (W911NF-17-1-0076); a Defense Advanced Research Projects Agency (DARPA) Young Faculty Award and Director Award grant (N66001-17-1-4044), and a Northrop Grumman grant.

Credit: 
University of Southern California

Biosensors to detect P. jirovecii, responsible for Pneumocystis pneumonia

image: Biosensors to detect P. jirovecii

Image: 
Instituto de Biomedicina de Sevilla

The group led by Dr. Enrique J. Calderón - "Clinical Epidemiology and Vascular Risk" at the Institute of Biomedicine of Seville - IBiS/University Hospitals Virgen del Rocío and Macarena/CSIC/University of Seville, also a member of CIBERESP, participated in a project with researchers from CIBER-BBN, in which they developed systems to detect Pneumocystis jirovecii, an atypical fungus responsible for very severe pneumonia in immunosuppressed patients. The results have been published in the journals Nanomaterials and Journal of Fungi, and are the fruit of collaboration with the CIBER-BBN groups led by Dr. Laura Lechuga, Dr. Ramon Eritja and Dr. Ramón Martínez Máñez.

Currently, the detection of the fungus in patients, who may be asymptomatic carriers until they develop pneumonia, uses the PCR technique, which takes several hours and requires adequate facilities and qualified personnel. However, the application of nanotechnology now makes it possible to develop more sensitive and efficient biosensors to detect specific sequences corresponding to pathogens responsible for infectious diseases in a shorter time and without the need for major infrastructure.

In this case, a specific sequence that corresponds to the gene belonging to the ribosomal subunit (mtLSU rRNA) of the fungus P. jirovecii has been detected using fork-shaped capture probes. These specific probes, "are more efficient and capable of recognising a specific genomic sequence of the fungus and forming very stable triplex structures that can be detected in different biosensor platforms," as Dr. Avignon, a CIBER-BBN researcher at the IQAC-CSIC, points out.

Using an optical biosensor based on SPR technology, Dr. Laura Lechuga's team at ICN2 was able to detect, in real time and without the use of markers, P. jirovecii in bronchoalveolar lavages and nasopharyngeal aspirates with a limit detection at the nM level and all in a matter of minutes.

Likewise, the group headed by Dr. Ramón Martínez-Máñez, scientific director of CIBER-BBN and principal investigator of the IQMA-IDM group at the Universitat Politècnica de València, used the strategy of molecular gates composed of an anodic albumin matrix to develop a sensor capable of efficiently detecting real samples of P. jirovecii without prior amplification steps in just one hour.

"These advances in the diagnosis of PcP have great potential for the development of highly sensitive point-of-care devices using samples taken straight from patients and are applicable in a wide variety of settings," says Dr. Enrique J. Calderón, internist at the Virgen del Rocío University Hospital in Seville and senior lecturer in the Department of Medicine.

The researchers also emphasise that these techniques are very selective and can discriminate patients with other respiratory pathologies derived from other microorganisms, thus enabling a more reliable diagnosis of infectious diseases.

Credit: 
University of Seville

In-silico modelling helps with the integrated study of the intervertebral disc in health and disease

The spinal column consists of 24 vertebrae that provide axial support to the torso and protection to the spinal cord that runs through its central cavity. The vertebrae are connected by means of intervertebral discs. These discs are highly hydrated, flexible and highly mechanically resistant. They allow the column its flexibility and act as shock absorbers during daily activities such as walking, running and in impact situations, such as jumping.

These unique features are made possible by the discs' tissue composition and structure. At its centre, there is a gel-like substance called nucleus pulposus (NP). This is surrounded by a fibrocartilage, the annulus fibrosus (AF), that laterally confines NP and enables high fluid pressure within, thus stabilizing the disc mechanically, like an inflated tyre. Upwards and downwards of the NP, are thin layers of cartilage (cartilage endplates, CEP), which separate the NP and the inner part of the AF of the vertebral bone (Fig 1). These layers of cartilage regulate the exchange of water and important biomolecules between the vertebrae and the NP, thus contributing to both the mechanics and the functional biological regulation of the disc.

A recent study published in the journal Bioinformatics presents a model to study the intervertebral disc resorting to experimental knowledge, and for the first time, network modelling solutions in systems biology, to mimic the cellular behaviour of NP cells exposed to a 3D multifactorial biochemical environment. This research has been carried out by members of the BCN MedTech Research Unit, a centre attached to the UPF Department of Information and Communication Technologies (DTIC), with Laura Baumgartner, a UPF PhD student as first author of the article, under the guidance of Jérôme Noailly, co-author of the study.

In-silico modelling to study intervertebral disc degeneration

Intervertebral disc degeneration is defined by a progressive loss of water and structure, and consequently of functionality. It differs from the natural ageing of the disc by the early onset of its symptoms, which has serious effects on the workforce. It is a major risk factor for chronic lower back pain, which can in turn cause disability.

The progressive degradation of the disc consists of accumulations of microscopic lesions, most likely caused by a (prolonged) alteration of the activity of local cells, which are essential to preserve tissue integrity. The factors leading to the change in this cell activity are not fully known and seem to be caused by interactions of multiple mechanical and biochemical stimuli, which limits in vivo or in vitro exploration. This lack of knowledge means that treatments for debilitating lower back pain are not able to solve the root problem, and so focus mainly on pain control with highly variable and short-term effectiveness.

In-silico modelling is particularly attractive because it allows integrating the influence of different stimuli on cells of the nucleus pulposus exposed to a 3D multifactorial environment. It also offers the chance to test a large number of possible scenarios of degeneration that might explain the great variability of clinical cases, which would be impossible by performing experiments.

As Laura Baumgartner explains in greater detail, "The in-silico modelling used in this study was the agent-based model, simulating a volume of 1mm³ with 4000 cells of the nucleus pulposus as agents. Cellular activity in the nucleus pulposus was estimated through the expression of messenger RNA of various components of the tissue that may be affected in the event of intervertebral degeneration: central proteoglycan proteins that form aggrecan aggregates and type I, II and III collagen, and two proteases that degrade the tissue, the enzyme stromelysin-1 (MMP-3) and ADAMTS, with a particular affinity for aggrecans". The values were obtained for inflamed and non-inflamed cells. In addition, cell viability was estimated by means of different biochemical profiles. The regulation of this cellular activity will determine the evolution of the composition of the disc tissues and their ability to maintain their integrity, retain water and fully undertake their role.

This advanced modelling, the first results of which have been validated, offers for the first time the possibility of predicting risk factors such as metabolic problems that can affect the nutrition of the intervertebral disc cells, deregulation problems of the inflammatory system that can lead to its over-activity, or morphological or mechanical risk factors, among others.

The study spawns a new horizon in the exploration of the intervertebral disc and its translation to better managing a large number of back pain problems. This potential will be explored in great depth in the new European project Disc4All (H2020-MSCA-ITN-ETN-2020 GA: 955.735), coordinated by Jérôme Noailly, which began in late 2020 and in which 15 theses are to be conducted focusing on the integrated description of disc degeneration mechanisms and on the exploitation of these descriptions to stratify patients with the ultimate goal of finding new therapeutic targets.

Advancing the knowledge of intervertebral disc regeneration

A later work published in January this year by the same authors in the International Journal of Molecular Sciences with international participants, presents an extensive review of previous work on the pathophysiology and advanced strategies of intervertebral disc regeneration. It provides an integrating analysis of the current knowledge of the multiscale function and the regulation of the intervertebral disc in health and disease, the potential regenerative strategies, and in-silico models that might provide support for the development of advanced therapies.

Credit: 
Universitat Pompeu Fabra - Barcelona

Trapping gases better with boron nitride "nanopores"

image: Schematic illustration of boron nitride and carbon structures and adsorption ability on porous boron nitride and carbon materials

Image: 
2021 Takahiro Ohkubo

What is common between a technology for storing energy in a solar cell and that for water purification? They both rely on the use of porous materials, or more specifically, "nanoporous" materials that can trap gas molecules within narrow spaces on their surface, called "pores", which are only nanometers (one-billionth of a meter) in size! In chemistry parlance, the phenomenon is known as "adsorption" and has played an important role in the synthesis of porous materials of different compositions, pore sizes, and even pore geometries.

Traditionally, activated carbon (AC, or a porous form of carbon) has been a popular adsorbent for practical applications owing to its higher capacity of adsorption than that of other porous materials. Lately, however, porous boron nitride (p-BN) has emerged as a promising alternative because of its impressive performance, as highlighted by a recent study claiming that p-BN can adsorb a relatively large amount of carbon dioxide at room temperature.

Now, a group of scientists from Okayama University and Nagasaki University, Japan, has put this claim to the test in their latest study, where they examined the adsorbing characteristics of p-BN in detail. "A BN unit and two carbon atoms (i.e., CC) both have the same number of electrons and similar structures, but their interaction with gas molecules are different due to the atomically heterogeneous nature of BN. Despite this, there has been very little research on BN materials. In our study, we wanted to see if BN has specific adsorption properties that cannot be observed in carbon materials," explains Dr. Takahiro Ohkubo from Okayama University, who led this study published in the journal RSC Advances.

To begin with, the scientists synthesized p-BN samples at high temperature conditions under presence of nitrogen and investigated their structure using X-ray diffraction, infrared (IR) spectra analysis, and high-resolution electron microscopy. The samples only differed from one another with respect to the temperatures at which they were synthesized. While X-ray diffraction data and IR revealed an "amorphous" phase (lacking well-defined structure) BN comprising "hexagonal phase" BN (h-BN) microcrystals for all samples, the one treated at 1673 K (1400°C), called p-BN-1673, showed the most ordered structure. After examining it under the electron microscope, the scientists found that this sample was composed of stacked layers of curved sheets with nanometer-size pores formed in between.

The scientists next looked at thermogravimetric curves of the samples to estimate their stability against oxidation and discovered that it was directly linked to the synthesis temperature, with higher temperatures entailing higher stability. Moreover, some additional species of carbon and oxygen were introduced into the h-BN crystal framework especially in p-BN-1473, giving rise to chemically active sites for nitrogen adsorption. While these species ordinarily reduce oxidation stability, the crystallinity of h-BN helped preserve it up to 973 K under normal conditions--a property not present in carbon-based adsorbents!

Finally, upon comparing the gas adsorption ability of p-BN and AC with nitrogen and argon as adsorbates, scientists observed that p-BN pores adsorbed nitrogen more strongly than argon and in relatively much larger amount (~ 150%-200%) than did AC. They attributed this observation to an additional physical interaction between nitrogen and p-BN pores that was absent for argon, and the creation of adsorption sites in p-BN by the impregnated carbon and oxygen species.

With these results, the Dr. Ohkubo and team are confident about the emergence of p-BN as a next-generation adsorbent material. "Given its superior oxidation stability and nature of adsorption, we are looking forward to the applications of porous BN as a novel adsorbent and catalyst support material, especially in cases where the use of carbon adsorbents is not feasible," comments Dr. Ohkubo.

Looks like carbon is about to go out of fashion on yet another front!

Credit: 
Okayama University

Anticancer drug may improve outcome for severe COVID-19 patients

image: Yihai Cao, professor
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet

Image: 
Ulf Sirborn

Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February and April 2020. On average, blood oxygen levels, body temperature and inflammatory markers significantly improved in patients treated with a single dose of bevacizumab in addition to standard care. The research is published in Nature Communications.

"To reduce COVID-19 mortality, we aim to develop an effective therapeutic paradigm for treating patients with severe COVID-19," says corresponding author Yihai Cao, professor of vascular biology at the Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet. "Our findings suggest that bevacizumab plus standard care is highly beneficial for patients with severe COVID-19 and should be considered as a potential first-line therapeutic regimen for this group."

Bevacizumab is a medication that has been used to treat various types of cancer since 2004. It works by slowing the formation of new blood vessels by inhibiting a growth factor known as VEGF. Many patients with severe COVID-19 have elevated levels of VEGF as well as symptoms associated with this marker, including excess fluid and disorganized blood vessels in the lungs. Against this background, the researchers designed a clinical trial to investigate the effect of combining bevacizumab with standard care for treating patients with severe COVID-19.

Twenty-six patients were recruited from two hospitals in China and Italy between mid-February and early April in 2020. The patients had confirmed COVID-19 and symptoms such as difficulty breathing, low blood oxygen levels and pneumonia. They were retrospectively matched with 26 patients of similar characteristics who received standard care at the same hospitals in roughly the same time period and thus served as the control group.

The recruits received standard care plus a single low dose of about 7.5 mg/kg bevacizumab, which markedly improved blood oxygen levels within 24 hours compared to the control group. By the end of the 28-day follow-up period, 92 percent of the bevacizumab-treated patients no longer needed the same level of oxygen support as before the trial began, compared with an improvement rate of 62 percent for the controls.

None of the bevacizumab-treated patients died and 17 (65 percent) improved so much that they were able to leave the hospital within the follow-up period. In the control group, three died and only 46 percent were discharged within 28 days. Bevacizumab also shortened the duration of oxygen-support to a median of nine days compared with 20 for the standard care group.

Other interesting findings include reduction in fever, an increase in white blood cells and a sharp decrease of c-reactive protein (CRP) levels, an inflammatory marker. No severe safety concerns were detected.

"Many patients with severe COVID-19 require significant oxygen support during long hospital stays, which pose global challenges to medical supplies," Yihai Cao says. "Our study shows that bevacizumab could help reduce the need for oxygen support and reduce days in hospital, thus improving the outcome for the individual patient while easing pressure on medical resources."

The limitations of the study include the non-randomized nature of the trial, the short-term follow-up and the small size of the cohort.

The next step will be to design randomized and placebo-controlled trials by recruiting a large number of patients, allowing further assessment of the potential benefits of bevacizumab both in and of itself and in combination with other therapies such as antivirals and anti-inflammatory drugs.

Credit: 
Karolinska Institutet

Non-teleost ray-finned fishes exhibit mosaic genomic features of lobe- and ray-finned fishes

A research team led by Prof. HE Shunping from the Institute of Hydrobiology (IHB) of the Chinese Academy of Sciences has discovered through genome sequencing that the non-teleost ray-finned fishes--bichir, paddlefish, bowfin and alligator gar--exhibit mosaic genomic features of lobe- and ray-finned fishes. The study was published in Cell.

The water-to-land transition during the Devonian is one of the most prominent events in vertebrate evolution. During this transition, various organs underwent adaptive changes, particularly those related to locomotion and respiration systems.

Rich fossil evidence suggests that many traits and functions related to this terrestrial evolution were present long before the ancestor of lobe- and ray-finned fishes appeared. Therefore, investigation of the genomes of extant species from early divergent lineages of ray-finned fishes may illuminate the genetic regulatory processes underlying trait evolution during the terrestrial transition.

The researchers produced a chromosome level assembly of the bichir (Polypterus senegalus), and draft genome assemblies for the American paddlefish (Polyodon spathula), the bowfin (Amia calva) and the alligator gar (Atractosteus spatula), which are representative species for each lineage of non-teleost ray-finned fishes.

The appearance of derived supporting appendicular structures was involved in the evolution of terrestrial locomotion, one of the major transitions in vertebrate evolution. Through comparative genomic analyses, the researchers found that early divergent lineages of ray-finned fishes exhibit many mosaic genomic features of lobe- and ray-finned fishes, particularly relating to regulatory elements for limb development.

The researchers then characterized olfactory receptor (OR) genes. Olfaction is important for vertebrate survival. Vertebrate genomes contain numerous OR genes, predominantly expressed in the olfactory epithelium of the nasal cavity. They found that non-teleost actinopterygians have mosaic OR features with a mixture of both types of OR genes, in accordance with the air-breathing characteristics of some species in these lineages.

To understand the evolution of lungs and their relationship to the swim bladders of fish, the researchers sequenced transcriptomes from 355 samples representing 10 tissues of eight vertebrate species. They confirmed that the lung and swim bladder are homologous organs, and discovered that functional lung-related genes are present in early ray-finned fishes.

In order to test the hypothesis that dominance of the conus arteriosus was an ancestral characteristic of the vertebrate cardiac outflow tract, the researchers functionally validated the essential role of a highly conserved element for cardiovascular development from a jawed vertebrate. The results implied that the ancestors of jawed vertebrates already had the potential gene networks for a cardio-respiratory system that could support air breathing.

The findings of this study are of great importance to understanding the water-to-land transition during vertebrate evolution since they clarify the genetic basis for limb development and for the respiratory system.

Credit: 
Chinese Academy of Sciences Headquarters

Computer can determine whether you'll die from COVID

Using patient data, artificial intelligence can make a 90 percent accurate assessment of whether a person will die from COVID-19 or not, according to new research at the University of Copenhagen. Body mass index (BMI), gender and high blood pressure are among the most heavily weighted factors. The research can be used to predict the number of patients in hospitals, who will need a respirator and determine who ought to be first in line for a vaccination.

Artificial intelligence is able to predict who is most likely to die from the coronavirus. In doing so, it can also help decide who should be at the front of the line for the precious vaccines now being administered across Denmark.

The result is from a newly published study by researchers at the University of Copenhagen's Department of Computer Science. Since the COVID pandemic's first wave, researchers have been working to develop computer models that can predict, based on disease history and health data, how badly people will be affected by COVID-19.

Based on patient data from the Capital Region of Denmark and Region Zealand, the results of the study demonstrate that artificial intelligence can, with up to 90 percent certainty, determine whether an uninfected person who is not yet infected will die of COVID-19 or not if they are unfortunate enough to become infected. Once admitted to the hospital with COVID-19, the computer can predict with 80 percent accuracy whether the person will need a respirator.

"We began working on the models to assist hospitals, as during the first wave, they feared that they did not have enough respirators for intensive care patients. Our new findings could also be used to carefully identify who needs a vaccine," explains Professor Mads Nielsen of the University of Copenhagen's Department of Computer Science.

Older men with high blood pressure are highest at risk

The researchers fed a computer program with health data from 3,944 Danish COVID-19 patients. This trained the computer to recognize patterns and correlations in both patients' prior illnesses and in their bouts against COVID-19.

"Our results demonstrate, unsurprisingly, that age and BMI are the most decisive parameters for how severely a person will be affected by COVID-19. But the likelihood of dying or ending up on a respirator is also heightened if you are male, have high blood pressure or a neurological disease," explains Mads Nielsen.

The diseases and health factors that, according to the study, have the most influence on whether a patient ends up on a respirator after being infected with COVID-19 are in order of priority: BMI, age, high blood pressure, being male, neurological diseases, COPD, asthma, diabetes and heart disease.

"For those affected by one or more of these parameters, we have found that it may make sense to move them up in the vaccine queue, to avoid any risk of them becoming inflected and eventually ending up on a respirator," says Nielsen.

Predicting respiratory needs is a must

Researchers are currently working with the Capital Region of Denmark to take advantage of this fresh batch of results in practice. They hope that artificial intelligence will soon be able to help the country's hospitals by continuously predicting the need for respirators.

"We are working towards a goal that we should be able to predict the need for respirators five days ahead by giving the computer access to health data on all COVID positives in the region," says Mads Nielsen, adding:

"The computer will never be able to replace a doctor's assessment, but it can help doctors and hospitals see many COVID-19 infected patients at once and set ongoing priorities."

However, technical work is still pending to make health data from the region available for the computer and thereafter to calculate the risk to the infected patients. The research was carried out in collaboration with Rigshospitalet and Bispebjerg and Frederiksberg Hospital.

Credit: 
University of Copenhagen - Faculty of Science

Technion researchers discover new pathway for attacking cancer cells

When treating cancer, researchers are always searching for ways to remove cancer cells while minimizing damage to the rest of the body. One possible approach is to find processes unique to cancer cells, and which would allow specific targeting. If such a process can be disrupted, only those cells would be affected.

A process (or absence thereof) can be unique to some types of cancer, and not be present in others. In such a case, we would want a simple way to recognize whether a particular tumor possesses the unique trait or not. The implication of this question is whether the tumor would respond to this or that treatment, allowing us to match a treatment to the patient who is likely to be helped by it, rather than going by trial and error.

Professor Tomer Shlomi's research group discovered just such a process - one that may be targeted in cancer cells without causing damage to healthy ones, findings that have been published in Cell Metabolism.

The folate cycle is a process essential to DNA and RNA production. As a result, it is highly important to both cancer cells and healthy cells. Because DNA production is a critical stage in cell division, and thus in tumor growth, the folate cycle is a common target for chemotherapy. However, for the very same reason, there are significant side effects to attacking it.

There are, in fact, two folate cycles - one happening in the mitochondria (an organelle inside the cell), and one in the cytosol (the fluid that fills the cell). A healthy cell can switch from one to the other. A variety of tumor cells, Professor Shlomi's group discovered, rely on the cytosolic pathway exclusively. The implication is, if treatment were to target the cytosolic folate cycle, healthy cells would switch to the mitochondrial cycle and would not be harmed, leaving tumor cells to die.

It remains to recognize whether a particular tumor is indeed one in which the mitochondrial folate cycle is non-functional, and here too Shlomi's team provided. RFC is a transporter protein that regulates intracellular folate levels. Low RFC - low folate. Low folate, the group discovered, is devastating to the mitochondrial cycle. So low RFC tumors are the ones that would be affected by cytosolic cycle-blocking treatments.

Both the pathway that may be attacked, and the way to recognize which tumors the attack would be effective against have thus been found.

Credit: 
Technion-Israel Institute of Technology

Machine learning generates realistic genomes for imaginary humans

image: A chromosome emerges from random digital noise.

Image: 
Burak Yelmen

Machines, thanks to novel algorithms and advances in computer technology, can now learn complex models and even generate high-quality synthetic data such as photo-realistic images or even resumes of imaginary humans. A study recently published in the international journal PLOS Genetics uses machine learning to mine existing biobanks and generate chunks of human genomes which do not belong to real humans but have the characteristics of real genomes.

"Existing genomic databases are an invaluable resource for biomedical research, but they are either not publicly accessible or shielded behind long and exhausting application procedures due to valid ethical concerns. This creates a major scientific barrier for researchers. Machine-generated genomes, or artificial genomes as we call them, can help us overcome the issue within a safe ethical framework," said Burak Yelmen, first author of the study and Junior Research Fellow of Modern Population Genetics at the University of Tartu.

The pluridisciplinary team performed multiple analyses to assess the quality of the generated genomes compared to real ones. "Surprisingly, these genomes emerging from random noise mimic the complexities that we can observe within real human populations and, for most properties, they are not distinguishable from other genomes from the biobank we used to train our algorithm, except for one detail: they do not belong to any gene donor," said Dr Luca Pagani, one of the senior authors of the study and a Mobilitas Pluss fellow.

The study additionally involves the assessment of the proximity of artificial genomes to real genomes to test whether the privacy of the original samples is preserved. "Although detecting privacy leaks among thousands of genomes could appear as looking for a needle in a haystack, combining multiple statistical measures allowed us to check all models carefully. Excitingly, the detailed exploration of complex leakage patterns can lead to improvements in generative model evaluation and design, and will fuel back the machine learning field," said Dr Flora Jay, the coordinator of the study and CNRS researcher in the Interdisciplinary computer science laboratory (LRI/LISN, Université Paris-Saclay, French National Centre for Scientific Research).

All in all, machine learning approaches had provided faces, biographies and multiple other features to a handful of imaginary humans: now we know more about their biology. These imaginary humans with realistic genomes could serve as proxies for all the real genomes which are not publicly available or require long application procedures or collaborations, hence removing an important accessibility barrier in genomic research, in particular for underrepresented populations.

Credit: 
Estonian Research Council

Study highlights risk of new SARS-CoV-2 mutations emerging during chronic infection

SARS-CoV-2 mutations similar to those in the B1.1.7 UK variant could arise in cases of chronic infection, where treatment over an extended period can provide the virus multiple opportunities to evolve, say scientists.

Writing in Nature, a team led by Cambridge researchers report how they were able to observe SARS-CoV-2 mutating in the case of an immunocompromised patient treated with convalescent plasma. In particular, they saw the emergence of a key mutation also seen in the new variant that led to the UK being forced once again into strict lockdown, though there is no suggestion that the variant originated from this patient.

Using a synthetic version of the virus Spike protein created in the lab, the team showed that specific changes to its genetic code - the mutation seen in the B1.1.7 variant - made the virus twice as infectious on cells as the more common strain.

SARS-CoV-2, the virus that causes COVID-19, is a betacoronavirus. Its RNA - its genetic code - is comprised of a series of nucleotides (chemical structures represented by the letters A, C, G and U). As the virus replicates itself, this code can be mis-transcribed, leading to errors, known as mutations. Coronaviruses have a relatively modest mutation rate at around 23 nucleotide substitutions per year.

Of particular concern are mutations that might change the structure of the 'spike protein', which sits on the surface of the virus, giving it its characteristic crown-like shape. The virus uses this protein to attach to the ACE2 receptor on the surface of the host's cells, allowing it entry into the cells where it hijacks their machinery to allow it to replicate and spread throughout the body. Most of the current vaccines in use or being trialled target the spike protein and there is concern that mutations may affect the efficacy of these vaccines.

UK researchers within the Cambridge-led COVID-19 Genomics UK (COG-UK) Consortium have identified a particular variant of the virus that includes important changes that appear to make it more infectious: the ΔH69/ΔV70 amino acid deletion in part of the spike protein is one of the key changes in this variant.

Although the ΔH69/ΔV70 deletion has been detected multiple times, until now, scientists had not seen them emerge within an individual. However, in a study published today in Nature, Cambridge researchers document how these mutations appeared in a COVID-19 patient admitted to Addenbrooke's Hospital, part of Cambridge University Hospitals NHS Foundation Trust.

The individual concerned was a man in his seventies who had previously been diagnosed with marginal B cell lymphoma and had recently received chemotherapy, meaning that that his immune system was seriously compromised. After admission, the patient was provided with a number of treatments, including the antiviral drug remdesivir and convalescent plasma - that is, plasma containing antibodies taken from the blood of a patient who had successfully cleared the virus from their system. Despite his condition initially stabilising, he later began to deteriorate. He was admitted to the intensive care unit and received further treatment, but later died.

During the patient's stay, 23 viral samples were available for analysis, the majority from his nose and throat. These were sequenced as part of COG-UK. It was in these sequences that the researchers observed the virus's genome mutating.

Between days 66 and 82, following the first two administrations of convalescent sera, the team observed a dramatic shift in the virus population, with a variant bearing ΔH69/ΔV70 deletions, alongside a mutation in the spike protein known as D796H, becoming dominant. Although this variant initially appeared to die away, it re-emerged again when the third course of remdesivir and convalescent plasma therapy were administered.

Professor Ravi Gupta from the Cambridge Institute of Therapeutic Immunology & Infectious Disease, who led the research, said: "What we were seeing was essentially a competition between different variants of the virus, and we think it was driven by the convalescent plasma therapy.

"The virus that eventually won out - which had the D796H mutation and ΔH69/ΔV70 deletions - initially gained the upper hand during convalescent plasma therapy before being overtaken by other strains, but re-emerged when the therapy was resumed. One of the mutations is in the new UK variant, though there is no suggestion that our patient was where they first arose."

Under strictly-controlled conditions, the researchers created and tested a synthetic version of the virus with the ΔH69/ΔV70 deletions and D796H mutations both individually and together. The combined mutations made the virus less sensitive to neutralisation by convalescent plasma, though it appears that the D796H mutation alone was responsible for the reduction in susceptibility to the antibodies in the plasma. The D796H mutation alone led to a loss of infection in absence of plasma, typical of mutations that viruses acquire in order to escape from immune pressure.

The researchers found that the ΔH69/ΔV70 deletion by itself made the virus twice as infectious as the previously dominant variant. The researchers believe the role of the deletion was to compensate for the loss of infectiousness due to the D796H mutation. This paradigm is classic for viruses, whereby escape mutations are followed by or accompanied by compensatory mutations.

"Given that both vaccines and therapeutics are aimed at the spike protein, which we saw mutate in our patient, our study raises the worrying possibility that the virus could mutate to outwit our vaccines," added Professor Gupta.

"This effect is unlikely to occur in patients with functioning immune systems, where viral diversity is likely to be lower due to better immune control. But it highlights the care we need to take when treating immunocompromised patients, where prolonged viral replication can occur, giving greater opportunity for the virus to mutate."

Credit: 
University of Cambridge

Birds living in natural habits can help inform captive care

Bird species that live in their natural habitats can help zoos learn how to manage those in captivity, according to a new review.

Birds are the most diverse group housed by zoos around the world, but zoo-based research tends not to focus on birds.

A new article published in the journal Birds, by Dr Paul Rose of the University of Exeter, suggests zoos can improve management of birds by looking at how species live in their natural habitats.

Likewise, birds living under the care of humans can also help guide and develop conservation action for those living in the wild.

"Research into wild birds is extremely useful for furthering how birds are managed in zoos," said Dr Rose.

"For species of conservation concern, zoo professionals can be linked with field biologists to share information on how to best care for these species in captivity and how to develop and formulate conservation actions.

"We can use proxy species - those common in zoos - to develop practices for conservation that can be used for less familiar species that might be of concern and need help from information gathered through things such as captive breeding.

"Or we can promote the threats that these not-in-the-zoo species face by using the commoner species as an ambassador.

"We do this through my work at the Wildfowl & Wetlands Trust, promoting the rarer species of flamingo that are in the wild using the commoner ones we keep in the living collection."

In the review, Dr Rose uses hornbills as an example, a species of bird that is essential to the long viability and sustainability of biodiversity in the rainforest.

The helmeted hornbill, a critically endangered species, plays an important role in the dispersal of seeds within pristine, undistributed areas of south-east Asian rainforests.

The population decline of the helmeted hornbill has been caused by poaching of the birds for their "ivory", the large casque on the bird's head and bill that can be up to 10% of its overall body mass.

Whilst the helmeted hornbill is not found in captivity, other species of large hornbill are.

By looking at the ecological role of the helmeted hornbill in its natural habitat, zoos have been able to design enclosures that will increase chances of reproduction.

For example, by identifying the temperature and humidity range of hornbill nesting sites in the wild which are more likely to hatch eggs, zoos have been able to use this data to enable them to match these environmental conditions as closely as possible.

A similar situation happened with the Guam kingfishers, a species that is extinct in the wild and reliant on captive breeding for its survival.

Data from the nesting locations of the closely related Pohnpei kingfisher, found on a neighbouring island, showed that temperatures were hotter than those sometimes provided for captive Guam kingfishers.

The findings led to zoos raising the temperature to improve nesting success amongst the species.

Zoos have also been able to guide conservation action for hornbills living in the wild by monitoring the behaviour of these birds and discovering that using nest boxes enhances the quality of habitats for hornbills to breed in, which has led to these boxes being built in areas of the helmeted hornbill's range in Borneo.

Expertise and financial support has been provided by several large zoological collections in European Association of Zoos and Aquaria (EAZA) and North American Association of Zoos and Aquariums (AZA) that has successfully seen wild rhinoceros hornbills, listed as vulnerable, fledge a chick from an artificial nest box in the Bornean rainforest.

"The effect of visitors on zoos can also help direct future research questions and increase understanding of birds under human care," adds Dr Rose.

"Developing zoo bird exhibits to theme them around specific conservation messages can be used to promote wider understanding of the threats faced by wild birds specifically and hopefully encourage human behaviour change that benefits ecosystem health."

Credit: 
University of Exeter

Link found between time perception, risk for developmental coordination disorder

image: A researcher helping a child participant wearing an EEG cap, a non-invasive approach to measure the brain waves.

Image: 
Auditory Development Lab, McMaster University

Neuroscientists at McMaster University have found a link between children who are at risk for developmental coordination disorder (DCD), a common condition that can cause clumsiness, and difficulties with time perception such as interpreting changes in rhythmic beats.

Accurate time perception is crucial for basic skills such as walking and processing speech and music.

"Many developmental disorders, including dyslexia or reading difficulties, autism and attention deficits have been linked to deficits in auditory time perception," says Laurel Trainor, senior author of the study and founding director of the McMaster Institute for Music and the Mind.

Previous research has shown the brain networks involved in time perception often overlap with the motor control networks required for such activities as catching a ball or tapping along to musical beats. Until now, researchers had not investigated whether children with DCD tended to have auditory timing deficits, despite being at risk for dyslexia and attention deficits.

The study, published online in the journal Child Development, provides new evidence about that connection in children.

Developmental coordination disorder is a common but little-studied condition that affects approximately five to 15 per cent of all children, who can experience a wide range of difficulties with fine and/or gross motor skills. It can have profound and lifelong effects on everyday tasks such as get dressed, writing, and engaging in sports or play, and often interferes with learning, academic performance and socialization.

For this study, researchers recruited more than 60 children aged 6 and 7 years old, who underwent motor skills tests and were assessed either to be at risk for DCD or to be developing typically.

During the first study, each child was asked in a series of trials to pinpoint which of two sounds was shorter in time or had an off-beat rhythm. From this, researchers measured the threshold or smallest time difference at which each child could just barely make the correct judgement.

"We saw that indeed, children at risk for DCD were much less sensitive to time changes compared to typically developing children," says Andrew Chang, the lead researcher and graduate student in the Department of Psychology, Neuroscience & Behaviour at McMaster.

In the second experiment, researchers used EEG to measure the brain waves of children as they listened to a sequence of sounds that had been tweaked to include occasional timing deviations. Children at risk for DCD had slower brain activity in response to the unexpected timing deviants.

There are no medications to treat DCD, but physiotherapy and occupational therapy can help children improve muscle strength, balance and coordination.

"We know anecdotally that therapists sometimes incorporate regular rhythms into the physical therapy they give to children with DCD, and they have the impression this helps - for example that children can walk better when they walk to a rhythm." Chang explains.

"Although our current study did not directly investigate any intervention effects, the results suggest that music with salient and regular beats could be used for physiotherapy to help treat children," he says.

He points to motor rehabilitation featuring auditory cueing with metronomes or musical beats, which helps adult patients who have Parkinson's disease or are recovering from a stroke. Further research could help to determine whether similar therapies are useful for children with DCD, he says.

Credit: 
McMaster University

Pangolin coronavirus could jump to humans

Scientists at the Francis Crick Institute have found important structural similarities between SARS-CoV-2 and a pangolin coronavirus, suggesting that a pangolin coronavirus could infect humans.

While SARS-CoV-2 is thought to have evolved from a bat coronavirus, its exact evolutionary path is still a mystery. Uncovering its history is challenging as there are likely many undiscovered bat coronaviruses and, due to differences between bat coronaviruses and SARS-CoV-2, it is thought that the virus may have passed to humans via at least one other species.

In their study, published in Nature Communications, the scientists compared the structures of the spike proteins found on SARS-CoV-2, the most similar currently identified bat coronavirus RaTG13, and a coronavirus isolated from Malayan pangolins which were seized by authorities after being smuggled to China. They found that the pangolin virus was able to bind to receptors from both pangolins and humans. This differs to the bat coronavirus, which could not effectively bind with human or pangolin receptors.

Antoni Wrobel, co-lead author and postdoctoral training fellow in the Structural Biology of Disease Processes Laboratory at the Crick, says: "By testing if the spike protein of a given virus can bind with cell receptors from different species, we're able to see if, in theory, the virus could infect this species."

"Importantly here, we've shown two key things. Firstly, that this bat virus would unlikely be able to infect pangolins. And secondly that a pangolin virus could potentially infect humans."

The team used cryo-electron microscopy to uncover in minute detail the structure of the pangolin coronavirus' spike protein, which is responsible for binding to and infecting cells. While some parts of the pangolin virus' spike were found to be incredibly similar to SARS-CoV-2, other areas differed.

In terms of understanding the evolutionary path of SARS-CoV-2, this work does not confirm whether or not this pangolin virus is definitely part of the chain of evolution for SARS-CoV-2. But the findings do support various possible scenarios for how the coronavirus jumped from bats to humans. One potential route is that SARS-CoV-2 originated from a different, currently unknown bat coronavirus which could infect pangolins, and from this species it then moved to humans. Or alternatively, RaTG13 or a similar bat coronavirus might have merged with another coronavirus in a different intermediate species, other than a pangolin.

Donald Benton, co-lead author and postdoctoral training fellow in the Structural Biology of Disease Processes Laboratory at the Crick, says: "We still don't have evidence to confirm the evolutionary path of SARS-CoV-2 or to prove definitively that this virus did pass through pangolins to humans."

"However, we have shown that a pangolin virus could potentially jump to humans, so we urge caution in any contact with this species and the end of illegal smuggling and trade in pangolins to protect against this risk."

Steve Gamblin, group leader of the Structural Biology of Disease Processes Laboratory at the Crick says: "A lot is still to be uncovered about the evolution of SARS-CoV-2, but the more we know about its history and which species it passed through, the more we understand about how it works, and how it may continue to evolve."

This work builds upon previous studies from the Crick team, including research published in July 2020, which found that the bat coronavirus RaTG13 could not effectively bind to human receptors.

The team are continuing to examine the spikes of SARS-CoV-2 and related coronaviruses, including other bat viruses, to better understand the mechanisms of infection and evolution.

Credit: 
The Francis Crick Institute